The Vincent Cristofalo Rising Star Award in Aging Research lecture will feature an address by the 2020 recipient, Sean P. Curran, PhD. This award is given by the American Federation for Aging Research, Inc


In “Electronic Cognitive Screen Technology for Screening Older Adults With Dementia and Mild Cognitive Impairment in a Community Setting: Development and Validation Study” :e17332) the authors noted the need to revise the “Acknowledgments” section.In the originally published article, the Acknowledgments section read as follows:The development of EC-Screen is supported by The Hong Kong Jockey Club Charities Trust. We greatly appreciate the contributions of the Jockey Club Centre for Positive Ageing in the design and development of the EC-Screen, and Mindvivid Limited for program development of EC-Screen. We also thank Ms. Anthea Ng for her help in data collection and entry.This section has been revised to:We thank Professor JE Morley, Saint Louis University School of Medicine, USA, for having agreed to let us adapt his Rapid Cognitive Screen test into EC-Screen for older Chinese people. We are also grateful for the funding support from the Hong Kong Jockey Club Charities trust, and for the support of the Jockey Club Centre for Positive Ageing for its contribution in design and data collection. We appreciate the support from Mindvivid Limited in software development of EC-Screen. We also thank Ms. Anthea Ng, research assistant of the Division of Neurology at The Chinese University of Hong Kong, for her help in data collection and entry.The correction will appear in the online version of the paper on the JMIR Publications website on January 19, 2021, together with the publication of this correction notice. Because this was made after submission to PubMed, PubMed Central, and other full-text repositories, the corrected article has also been resubmitted to those repositories.


In the original article, we neglected to include the funder KideOn Research Group of the Basque Government, Ref.: IT1342-19 (A category).The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.


Jianzhong Li and Shasha Tao. As well as having affiliation(s) existed in the paper, they should also have Medical College of Soochow University, Suzhou, China as the first affiliation.In the published article, there was an error regarding the affiliation for The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.


Incorrect funding information is included in the Acknowledgments. The correct funding information should be included in the Funding statement and read as follows: The publication was co-financed within the framework of the Ministry of Science and Higher Education program as "Regional Initiative Excellence" in years 2019–2022 (Project No. 005 / RID / 2018/19). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


The raw data underlying the findings of this study  are missThe following information is missing from the Funding statement: This study was funded by grants to NA from Astex Inc. (GRANT # 120039) and the Van Andel Research Institute–Stand Up To Cancer Epigenetics Dream Team. Stand Up To Cancer is a program of the Entertainment Industry Foundation, administered by AACR.There is information missing from the Competing Interests statement. The correct Competing Interests statement is as follows: The authors of this manuscript have read the journal’s policies and have the following competing interests to declare: NA was the recipient of grants from Astex Inc. and the Van Andel Research Institute. Additionally, NA has served as consultant to Johnson & Johnson, an advisor to Celgene, and a member of the Scientific Advisory Council to the No Stomach for Cancer Foundation. There are no patents or marketed products to declare. This does not affect our adheres to PLOS ONE policies on sharing data and materials.S1 Data(ZIP)Click here for additional data file.


In “Improving Nutrition and Activity Behaviors Using Digital Technology and Tailored Feedback: Protocol for the Tailored Diet and Activity (ToDAy) Randomized Controlled Trial” :e12782), corrections have been made to the article title and to three places in the text to reflect that the term “LiveLighter” is a registered trademark.The original title of this paper was:Improving Nutrition and Activity Behaviors Using Digital Technology and Tailored Feedback: Protocol for the LiveLighter Tailored Diet and Activity (ToDAy) Randomized Controlled TrialThe title has been changed to:Improving Nutrition and Activity Behaviors Using Digital Technology and Tailored Feedback: Protocol for the Tailored Diet and Activity (ToDAy) Randomized Controlled TrialIn the originally published paper, the caption of Table 1 read:Table 1. Frequency of assessment of variables in the LiveLighter ToDAy study for the tailored feedback, active control, and online control groups.The caption of Table 1 has been changed to read:Table 1. Frequency of assessment of variables in the ToDAy study for the tailored feedback, active control, and online control groups.Under the first paragraph of the section "Process Evaluation" in the originally published paper, the sentence:Selected program completers and noncompleters (tailored feedback and active control groups) will be invited to participate in one-on-one interviews concerning their perceptions of the LiveLighter ToDAy intervention.has been replaced by the sentence:Selected program completers and noncompleters (tailored feedback and active control groups) will be invited to participate in one-on-one interviews concerning their perceptions of the ToDAy intervention.In the originally published paper, the Acknowledgments section read:Funding for the LiveLighter ToDAy study is provided by a Healthway Health Promotion Research Grant and the East Metropolitan Health Service. The mFR app is funded by NIH-NCI (1U01CA130784-01) and NIH-NIDDK . CC is supported by an NHMRC Senior Research Fellowship and a University of Newcastle –Gladys M Brawn Senior Research Fellowship. Funding for Fitabase is provided by a Curtin Institute of Computation grant. The sponsors had no role in the design of the study; collection, analyses, or interpretation of data; writing of the manuscript; and decision to publish the results.This section has been changed to read:Funding for the ToDAy study is provided by a Healthway Health Promotion Research Grant and the East Metropolitan Health Service. The mFR app is funded by NIH-NCI (1U01CA130784-01) and NIH-NIDDK . CC is supported by an NHMRC Senior Research Fellowship and a University of Newcastle –Gladys M Brawn Senior Research Fellowship. Funding for Fitabase is provided by a Curtin Institute of Computation grant. The sponsors had no role in the design of the study; collection, analyses, or interpretation of data; writing of the manuscript; and decision to publish the results. The term “LiveLighter” is a registered trademark. The LiveLighter campaign is funded by the Western Australian Department of Health and at the time of this study, delivered by the National Heart Foundation (WA Division), and currently delivered by Cancer Council Western Australia.The correction will appear in the online version of the paper on the JMIR Publications website on December 2, 2020, together with the publication of this correction notice. Because this was made after submission to PubMed, PubMed Central, and other full-text repositories, the corrected article has also been resubmitted to those repositories.


In the original article, we neglected to include the funder: Cancer Prevention Research Institute of Texas Training Grant (CPRIT RP170067) to Hannah Savage.The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.


Dear Dr. Yokokura:Congratulations on the launch of JMA Journal by the Japan Medical Association (JMA) and Japanese Association of Medical Sciences (JAMS). As an official English medical journal covering all aspects of medicine and medical care, including original research, health policy, and global health, I am sure it will be a success not only with clinical investigators in Japan, but worldwide. The publication of this type of comprehensive medical journal is the first challenge in Japan. We sincerely hope that the JMA Journal will promote international medical science and contribute to the improvement of the quality of health care by being read and cited by many people.If I or any of my staff can be of any help in this important endeavor please let us know.Good luck with this important initiative of the JMA and JAMS.Sincerely,Howard Bauchner, MDEditor in Chief, JAMA and the JAMA Network (2011-)Senior Vice-President, American Medical Association


The Editors highlight that the information presented in the original version was provided by the authors at submission and revision. In addition, the authors had the opportunity to correct the information during proofreading, before approving for publication.<renhaozhen1984@163.com> | Jinglin Wang <cw20120817@163.com>Correspondence: Haozhen Ren: Acknowledgments: This work was supported by grants from the Nanjing Medical Science and Technique Development Foundation (No. QRX17129), the Certificate of China Postdoctoral Science Foundation Grant (2018M642222), and the Jiangsu Province Natural Science Foundation (BK20190114).*These authors contributed equally to this study.


It is with great grief that we announce the loss of our friend and mentor, Professor Dr. Ovidiu Alexandru Băjenaru. It would be difficult to write of our beloved colleague in these pages without betraying emotion. A brilliant neurologist, researcher, teacher, husband, father, he leaves behind a profound legacy of perhaps the most influential contemporary figure in Romanian neurology.We remember and cherish some of his most significant achievements over his long and fruitful career. Professor Băjenaru is the founding President of the Romanian Society of Neurology (RSN), an organization that he has formally led for 12 years. In this position, he has contributed decisively to the advancement of science and education in our field. He spearheaded the development of a vision for clinical neurology in our country, based on the conceptual changes determined by colossal advances in neuroscience and modern medical technologies, and integrated using traditional clinical training.Professor Ovidiu Băjenaru represented Romania at top-notch medical forums. He was Romania’s official representative at the World Federation of Neurology (since 2001), the European Stroke Organization, and the European Union of Medical Specialists (Board of Neurology permanent representative of Romania since 2008). Dr. Băjenaru was also a corresponding member of the Romanian Academy (since 2016), as well as a member of the Romanian Group of Brain Research (since 2016), member in the Bureau of Medical Services (since 2018), member of the Academy of Medical Sciences (since 2013).His primary areas of interest were neurodegenerative diseases (particularly Parkinson’s disease and Alzheimer’s disease), muscular dystonia and other motor behavior abnormalities, cerebrovascular diseases, multiple sclerosis, and sleep pathology in neurological disorders and medical conditions – all fields in which he became a leading authority. His scientific activity includes over 500 presentations at national and international events and over 50 international multicentric clinical trials as a principal investigator.Professor Băjenaru coordinated the interdisciplinary medical group for the treatment by deep brain stimulation for Parkinson’s disease  from the Bucharest Emergency University Hospital (since 2006), the first Romanian medical group for the interventional treatment of epilepsy (since 2009), and the national health programs for neurological disorders of the National Health Insurance House and the Romanian Ministry of Health (since 2014). Between 2008-2014, he was the President of the Neurology and Pediatric Neurology Commission at the Romanian Ministry of Health.Among his original scientific contributions, as part his doctoral thesis defended in 1993, he introduced the concept of incipient cognitive impairment for the first time in Romania, referring to patients with cerebrovascular and coronary diseases who develop neurocognitive disorders as a condition preceding the onset of dementia. He has also promoted the implementation of systematic neurocognitive evaluation for patients with neurological and vascular diseases, as well as their treatment in the current pursuit/activity of the neurologists in Romania. Dr. Băjenaru conducted the first brain connectomics study in the context of a neurological condition (Parkinson’s Disease) in Romania. Under the coordination of Professor Băjenaru, a modern school of clinicians and researchers in neurosciences was born, forming several professors and heads of clinics and departments in Bucharest. Throughout his career, he has received numerous awards that certify the effort made and the unquestionable dedication which he had in helping those in need. Among the awards and distinctions received we mention the Romanian Patriarchate Award “100 years of Modern Medicine in the capital of united Romania” (2018), The Excellence Award for the entire activity in the field of Neurology in Romania of the Academica Foundation (2016), the Excellence Award for the whole of the activity of the Foundation Prof. Dr. Marin Voiculescu “(2015), Excellence Award of the International Brain Foundation and the Romanian Academy of Medical Sciences - for his activity in the field of neurology in Romania, (2014); Doctor Honoris Causa of the “Ovidius” University of Constanța, Romania (2006); Award of Excellence in Neurology in Romania - for scientific and educational activity at national level, 2005, 2006 and 2011; Romanian Society of Internal Medicine Award for the most active scientific collaborator in a related specialty, 2008, 2012; Excellency prize of the International Society for the Study of Neuroprotection and Neuroplasticity, 2011; Excellence Award for medical activity awarded by the Romanian Ministry of Health in 2015.He was an influencing neurologist, a fantastic colleague, and a dear friend. It is a great loss for all of us that he has passed away at such a young age. Although he is no longer with us, his powerful impact on our field will last for a very long time. Our deepest sympathy goes to his family in this time of grief.He will be greatly missed. May his soul rest in peace.


The National Institute on Aging (NIA) at the National Institutes of Health, Department of Health and Human Services, is the federally designated lead agency on aging research, and has supported significant research on aging as a life-long process. In the last five years, NIA experienced a tripling of its budget. Although much of this funding is targeted to Alzheimer’s disease (AD) and AD related dementias (ADRD) research, there was an increase in funds allocated to non-AD research in keeping with the overall growth of NIH. This symposium will provide a forum for exploration of the implications of the budget increases for the general research community. It will involve NIA’s senior staff discussing research priorities and programs supported by the Institute. A question-and-answer session will follow brief introductory remarks on current funding and future priorities and research directions of NIA.


The fourth speaker is Dr. Erica Solway. Dr. Solway will discuss her experience working in policy at the federal level as a Health and Aging Policy Fellow and a policy advisor with the U.S. Senate Committee on Health, Education, Labor, and Pensions Subcommittee on Primary Health and Aging and in her current involvement in policy-relevant research at the state and national level at the University of Michigan Institute for Healthcare Policy & Innovation. Dr. Solway is a senior project manager forthe evaluation of the Healthy Michigan Plan, Michigan’s Medicaid expansion program, and is also an associate director of the University of Michigan National Poll on Healthy Aging.


The authors wish to add the following statement in the Acknowledgements section of this paper :The authors would like to acknowledge Dr. Natália Tobar, Division of Nuclear Medicine, Department of Radiology, School of Medical Sciences, University of Campinas, for the excellent acquisition and discussion of animal parameters by DEXA.The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected.


The session will also include the presentation of the2020 Lawton Award to recipient Sara J. Czaja, PhD, FGSA. The M. Powell Lawton Award is presented annually to an individual who has made outstanding contributions from applied research that has benefited older people and their care. The Lawton Award is generously funded by the Polisher Research Institute of the Madlyn and Leonard Abramson Center for Jewish Life.”


Health Resources and Service Administrator-HRSA, grant # K01HP33459 to Dr. Tabrizi. These statements should also be added per funders request.In the original article, we neglected to include the funder “This publication was made possible by Grant Number K01HP33459 from the Health Resources and Services Administration (HRSA), an operating division of the U.S. Department of Health and Human Services. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Health Resources and Services Administration or the U.S. Department of Health and Human Services.”The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.


The funding statement for this article should read as follows:“The research was supported by grants from the European Research Council , the Israel Science Foundation to MS (300/17) and through its Center of Excellence in Structural Cell Biology to SJF and DF (1775/12), a research grant from Sheri and David E. Stone and by a charitable donation from Sam Switzer and family. M.S. is an incumbent of the Aharon and Ephraim Katzir Memorial Professorial Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”


There are errors in the Funding statement. The correct Funding statement is as follows: This research/work was supported by the Cluster of Excellence Cognitive Interaction Technology 'CITEC' (EXC 277) at Bielefeld University to SF and AM, which is funded by the German Research Foundation (DFG).


Correction to:Perspect Med Educ 201910.1007/s40037-019-00558-zUnfortunately information regarding Paul Worley’s affiliation is missing from the original article. Please find the information here:Paul Worley is affiliated to the Prideaux Centre for Research in Health Professions Education, Flinders University, Adelaide, Australia. He is the Australian National Rural Health Commissioner. This is an independent statutory position. The views in this paper are those of the authors only and do not represent the views of the Australian Government or the Department of Health.


There is an error in the Funding statement. The correct number for the National Natural Science Foundation of China is No. 81771231, 81471156 to HJ and No. 81600995 to YS.the National Natural Science Foundation of China, No. 81974176 to HJ, 81901169 to ZC, No. 81901305 to CW.We also neglected to include the funder The final funding part is as follows:This study was supported by the National Key Research and Development Program of China (Nos. 2016YFC0901504 and 2016YFC0905100 to HJ and No. 2016YFC1306000 to BT), the National Natural Science Foundation of China , the Key Research and Development Program of Hunan Province (No. 2018SK2092 to HJ), the Scientific Research Foundation of Health Commission of Hunan Province (No. B2019183 to HJ), and the Clinical and Rehabilitation Fund of Peking University Weiming Biotech Group (No. xywm2015I10 to HJ).The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.


In the published article, there was an error regarding the affiliations for Sean M. Bialosuknia. Instead having affiliations 1,2,3, they should have affiliations 1,3.In the original article, we neglected to include funding from Pacific Southwest Regional Center of Excellence for Vector-Borne Diseases funded by the U.S. Centers for Disease Control and Prevention (Cooperative Agreement 1U01CK000516) to Erin Taylor Kelly and Geoffrey M. Attardo.This publication was supported by the Cooperative Agreement Number U01CK000509 funded by the Center for Disease Control and Prevention. Its content is solely the responsibility of the authors and do not necessarily represent the official views of the Center for Disease Control and Prevention or the Department of Health and Human Services. The study received funding from Pacific Southwest Regional Center of Excellence for Vector-Borne Diseases funded by the U.S. Centers for Disease Control and Prevention (Cooperative Agreement 1U01CK000516), to EK and GA. We would like to extend our gratitude to Illia Rochlin of Suffolk County Health Department for providing us with Ae. albopictus mosquitoes and the Arbovirus laboratory insectary crew for mosquito maintenance. Data for these analyses were acquired at the University of California, Davis West Coast Metabolomics Center, U2C ES030158. We would like to express our gratitude to Dr. Alice Trimmer for her suggestions and edits.The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.


The following information is missing from the Funding statement: This study was funded in part by the Deputyship for Research and Innovation, ‘Ministry of Education’ in Saudi Arabia through the Project no. IFKSURP-160. No additional external funding was received for this study.The following information is missing from the Acknowledments section: The author extends their appreciation to the Deputyship for Research and Innovation, ‘Ministry of Education’ in Saudi Arabia for funding this research work through the Project no. IFKSURP-160. Special thanks for Dr Emad Mahmoud, an assistant professor, and senior researcher at King Saud University, for the support in evaluating the eligibility of the articles for inclusion in this systematic review and meta-analysis.


Since 2015, The John A. Hartford Foundation has been funding strategies to create Age-Friendly Health Systems (AFHS). Led by the Institute of Healthcare Improvement, in partnership with the American Hospital Association and the Catholic Health Association, the AFHS movement is rapidly growing, with participation in all 50 states from over 450 sites, including the full continuum of care settings. Partnerships with private and public entities are accelerating the work. As one example, the Health Resources and Services Administration has embedded AFHS principles into the Geriatrics Workforce Enhancement Program. This Kent Lecture will focus on the genesis and trajectory of the AFHS social movement and discuss how the effort will lead to an age-friendly ecosystem that transcends boundaries and cultures and leads to a common framework for the way we approach care, caregiving and communities for optimizing the lives and wellbeing of all older adults.


In the original article, we neglected to include the funder, the Jacobs Foundation, Grant: 015 11 63 00 to Kate Ellis-Davies.The updated Funding section reads as follows:This research was supported, under the auspices of the Open Research Area , by grants from the UK Economic and Social Research Council , The Netherlands Organisation for Scientific Research , the French Agence Nationale de la Recherche , and the Jacobs Foundation (Grant 015 11 63 00 to KE-D) whose support is gratefully acknowledged.The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.


There are errors in the Funding statement. The publisher apologizes for these errors. The correct Funding statement is as follows: This Collection was supported by TEPHINET, a program of The Task Force for Global Health, Inc., via Cooperative Agreement number NU2GGH001873, funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention, the U.S. Department of Health and Human Services, The Task Force for Global Health, Inc., or TEPHINET.


Cross-border partner interactions were supported by the EU Twinning project VACTRAIN #692293 and PI project of the Swedish Institute #19806_2016. Participation of Petkov S, Chiodi F, and Wahren B was supported by VACTRAIN. Participation of Svirskis S was supported by BALTINFECT.There are errors in the Funding statement. The grant number listed from the Russian Foundation of Basic Research is actually from the Russian Science Foundation. The correct Funding statement is as follows: The study was supported by the Russian Foundation of Basic Research project #17_04_00583 Click here for additional data file.


European Immunization Week (EIW) 2020, the European Vaccination Information Portal was launched on 21 April. This publically accessible website provides anyone interested in vaccination with accurate, objective and up-to-date evidence on vaccines and vaccination with an European Union (EU) perspective.On the occasion of Council Recommendation on Strengthened Cooperation against Vaccine Preventable Diseases adopted in December 2018. The portal, which is available in all of the EU’s official languages, features an overview of the existing mechanisms in the EU to ensure that available vaccines conform to the highest standards of safety and effectiveness. It also highlights the benefits of vaccination to the individual and the community. The project is an initiative of the EU, following the The website was developed by the European Centre for Disease Prevention and Control (ECDC), in partnership with the European Commission (EC), specifically, the Directorate-General for Health and Food Safety (DG SANTE) and the European Medicines Agency (EMA).here.EIW, which is led and coordinated by the World Health Organization Regional Office for Europe (WHO/Europe), is marked across the WHO European Region every April. It aims to raise awareness of the importance of immunisation for people’s health and well-being. ECDC supports the EIW campaign by providing scientific evidence on immunisation. Information on ECDC activities in the context of EIW can be found


The New York City Department of Health and Mental Hygiene, Bureau of Alcohol and Drug Use Prevention, Care and Treatment affiliation should not have been included for Ms Warren. In addition, Dr Kolodny should have been named as the corresponding author instead of Ms Warren. This article has been corrected.1In the Research Letter titled “Trends in Heroin Treatment Admissions in the United States by Race, Sex, and Age,”


Dr. Takashi Sugimura, an honorary member of the Japanese Environmental Mutagen Society (JEMS), passed away on September 6, 2020, at the age of 94. Dr. Sugimura was a leading international figure in cancer medicine for many years, and was a pioneer in molecular biology. He graduated from the University of Tokyo, Faculty of Medicine, in 1949, received his Ph.D. in 1957, and went abroad to study at the National Cancer Institute in the United States. He then joined the National Cancer Center Research Institute in Tokyo in 1962 and was appointed Director in 1974. He later concurrently served as a Professor of Molecular Oncology at the Institute of Medical Science in the University of Tokyo from 1970 to 1988. He was appointed to be President of the National Cancer Center in 1984 and was instrumental in promoting the government’s Comprehensive 10-Year Strategy for Cancer, which was launched that year, and was appointed Honorary President of the National Cancer Center in 1992. He also served as President of Toho University from 1994 to 2000, and was named President Emeritus in 2000. In 2003, he was diagnosed with stomach cancer and had his entire stomach removed. In an effort to help other patients and their families, he wrote a book about the testing and treatment process and his life after surgery, and continued to work on the development of cancer treatments from the patient’s perspective.Dr. Sugimura’s research clarified the relationship between mutagenicity and carcinogenicity and produced major contributions to the scientific study of cancer development mechanisms. He is especially remembered for his work on the now-well-known fact that cancer is a disease caused by genetic mutations. Together with Dr. Minako Nagao (who later became Chief of the Carcinogenesis Division) and other researchers, he showed that common cooking practices can produce mutagens exhibiting the same structures as those of heterocyclic amines in food. He then isolated and identified a large number of these heterocyclic amines, and showed that they are taken into the body via food consumption and induce mutations in genes, resulting in the development of tumors. He also analyzed multi-step carcinogenesis at the molecular level and studied its relevance to potential avenues for the prevention of cancer. This research has significantly impacted the identification of new mechanisms of chemical carcinogenesis and tumor promotion.Dr. Sugimura was the second President of JEMS for 4 years from 1978 and was the chairman of 5th meeting of JEMS hosted in 1976 in Tokyo. In 1981, he was a President for Third International Conference of Environmental Mutagens, which was held in Tokyo Japan and hosted by JEMS on behalf of International Association of Environmental Mutagen Societies . He also became an honorary member of JEMS in 1987, and was a frequent lecturer at annual JEMS meetings. In addition, in 1994, when the JEMS Award was established, the first prize was awarded for his “Research on the mutagenicity and carcinogenicity of heterocyclic amines.”The International Symposium of the Princess Takamatsu Cancer Research Fund, held in Tokyo every autumn, introduces the in latest cancer research and provides a forum for interaction between foreign and domestic researchers. Dr. Sugimura served as the Chair of the Scientific Advisory Committee for this fund for 25 years, from 1989 to 2014, and made significant contributions to the Fund’s activities, including playing a key role in establishing the AACR Princess Takamatsu Memorial Lecture Prize in 2007. He was also instrumental in the establishment of the successful Joint Conference of the American Association for Cancer Research and the Japanese Cancer Association, which began in 1989, and he co-chaired the first meeting with the former President of the AACR, Dr. Enrico Mihich. This joint conference is held every 3 years in Hawaii, and continues to symbolize the close relationship between cancer science researchers in Japan and the United States.Dr. Sugimura’s work has been recognized in the United States as well in Japan, appearing five times on the cover of Cancer Research. He has also been the recipient of multiple honors in the United States, with his election as a member of the AACR in 1969, an honorary member in 1980, and the first fellow of the AACR Academy in 2013. His accomplishments are too numerous to list in full here, so I will only list some of the major awards he has received as evidence of his high esteem: the Imperial Prize and Japan Academy Prize in 1976, the EMS Award from the Environmental Mutagen Society  in 1978, the Order of Culture of the Japanese Government in 1978, the Charles S. Mott Prize from the General Motors Cancer Research Foundation in 1981, the Tomizo Yoshida Prize from the Japanese Cancer Association in 1992, and the Japan Prize for Biotechnology in Medicine in 1997. He also served as the 25th President of the Japan Academy in 2013–16. He was an elected foreign associate of the National Academy of Sciences and the Institute of Medicine (U.S.), and an elected foreign member of the Royal Netherlands Academy of Arts and Sciences and the Royal Swedish Academy of Sciences.There is an expression in Japanese, “fall of a giant star.” In the field of genotoxicity and cancer research, Dr. Sugimura’s death may be best described using this expression. It is an undeniable fact that Dr. Sugimura was and will continue to be respected for his intellectual contributions to research, his amazing leadership skills, and his supreme passion for research above all.May he rest in peace.Editor-in-ChiefMasami YamadaNational Defense Academy of Japan


In the published article, there was an error regarding the affiliation for Lidan Sun. Instead of affiliation 3, it should be 2.In addition, there is an error in the order of the Funding statement. The correct statement appears below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.This research is supported by the National Natural Science Foundation of China (No. 31870689), the Fundamental Research Funds for the Central Universities (NO. 2015ZCQ-SW-06), the National Natural Science Foundation for Young Scientists of China , and grant 201404102 from the State Administration of Forestry of China.


The authors wish to make the following erratum to this paper . The FunThis research was funded by project (RTI2018-093321-B-I00) supported by: ERDF , Ministry of Science and Innovation and State Research Agency from Spain.Life editorial office has been asked to update the original manuscript [The authors would like to apologize for any inconvenience caused to the readers by these changes. The nuscript  on the a


There are errors in the Funding statement. The correct Funding statement is as follows: This Collection was supported by TEPHINET, a program of The Task Force for Global Health, Inc., via Cooperative Agreement number NU2GGH001873, funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention, the U.S. Department of Health and Human Services, The Task Force for Global Health, Inc., or TEPHINET.


The past 5 years have seen incredible advances in approaching hearing loss as a major public health issue. National efforts include the 2015 President’ Council of Advisors on Science and Technology and the National Academies of Science, Engineering, & Medicine’s 2016 Commission on Hearing Health Care for Adults, which led to the 2017 OTC hearing aid legislation and the expected debut of OTC hearing aids in 2020-2021. The World Report on Hearing amplifies these efforts. This presentation will cover the role of the Report in the context of the rapidly evolving hearing care landscape in the US and how the Report’s call for affordable, accessible hearing care fit within current national efforts focused on older adults. Finally, the WHO recognized 2020-2030 as the Decade of Healthy Aging. We will discuss how the World Report on Hearing integrates with broader efforts to support healthy aging locally and globally.


The Clark Tibbitts Award lecture will feature an address by the 2020 award recipient, Jan Abusharkrah, PhD, FAGHE. AGHE’s Clark Tibbitts Award was established in 1980 and named for an architect of the field of gerontological education. The award is given each year to an individual or organization that has made an outstanding contribution to the advancement of gerontology and geriatrics education.


The manuscript draft was developed by KL, MG, and MKG. All authors contributed to the article and approved the submitted version.YL is supported by National Key Research and Development Program of China (2017YFC1310405) and the National Natural Science Foundation of China (U1736124). MKG is supported by the Bekker programme grant of the Polish National Agency for Academic Exchange (PPN/BEK/2019/1/00245/U/00001).The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.


In 2015, the Program of Merit was expanded and adapted to implement a voluntary evaluation process for health professions programs that are choosing to integrate gerontology/geriatrics competencies in order to prepare students for working with older adults as well as their informal care partners. These programs are now eligible to apply for the Program of Merit designation. The Program of Merit for Health Professions Programs is based on the AGHE Standards and Guidelines for Gerontology/ Geriatrics in Higher Education, Sixth Edition (2015), specifically Chapters 11 and 12. This session will provide an overview of the process, review the application content, and provide technical support for interested participants.


Correction to: BMC Pregnancy and Childbirth (2020) 20:257https://doi.org/10.1186/s12884-020-02951-7Following publication of the original article , the autAcknowledgementsWe would like to thank the team of the Netherlands’ Course on Global Health and Tropical Medicine of the KIT Royal Tropical Institute in Amsterdam for passionately teaching the determinants of health model. The lectures and assignments of the course led to the first draft of this paper. Especially the guidance and support of Maaike Flinkenflögel was of great value. We thank professor Florence Mirembe from the Department of Obstetrics and Gynaecology of the Makerere University College of Health Sciences in Kampala, Uganda, for sharing her thoughts after reading our manuscript.


There is information missing from the Funding statement. The complete, correct Funding statement is as follows: This research was made possible in part by a grant from NOAA Fisheries, Office of Protected Resources, Species of Concern Program, in part by a grant from The Gulf of Mexico Research Initiative, and in part by funding from the Florida Fish and Wildlife Conservation Commission (Grants FWC-08304 and FWC-16188 to WFP). Riverside Technology, Inc. provided support in the form of salary for author LT, but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.The publisher apologizes for the error.https://data.gulfresearchinitiative.org (doi:10.7266/N7W37TWR).The following information is missing from the Data Availability statement: Dissolved inorganic carbon 14C data are publicly available through the Gulf of Mexico Research Initiative Information & Data Cooperative (GRIIDC) at


The National Institute on Aging (NIA) at the National Institutes of Health, Department of Health and Human Services, is the federally designated lead agency on aging research, and has supported significant research on aging as a life-long process. In the last five years, NIA experienced a tripling of its budget. Although much of this funding is targeted to Alzheimer’s disease (AD) and AD related dementias (ADRD) research, there was an increase in funds allocated to non-AD research in keeping with the overall growth of NIH. This symposium will provide a forum for exploration of the implications of the budget increases for the general research community. It will involve NIA’s senior staff discussing research priorities and programs supported by the Institute. A question-and-answer session will follow brief introductory remarks on current funding and future priorities and research directions of NIA.


The authors of “Postvaccination Fever Response Rates in Children Derived Using the Fever Coach Mobile App: A Retrospective Observational Study” :e12223) identified an error in the Acknowledgements section.In the first part of the Acknowledgements section, the following phrase:This work was supported by Technology Innovation Program (10060085) funded by the Ministry of Trade, Industry, and Energy Has been changed to:This work was supported by Technology Innovation Program (20002289) funded by the Ministry of Trade, Industry, and Energy The correction will appear in the online version of the paper on the JMIR website on May 7, together with the publication of this correction notice. Because this was made after submission to PubMed, PubMed Central, and other full-text repositories, the corrected article has also been resubmitted to those repositories.


The following information is missing from the Funding statement: This paper is an output of a research project implemented as part of the Basic Research Program at the National Research University Higher School of Economics (NRU HSE).There is an error in affiliation 1 for authors Iuliia Naidenova, Petr Parshakov, and Aleksei Chusovliankin. The correct affiliation 1 is: HSE University, Perm, Russia.


The authors wish to make the following corrections to this paper . The authors would like to acknowledge Dr. Ali Khammanivong for providing gRNA sequences and guidance during the generation of the CD44 knockout cell lines. The authors would also like to acknowledge the Burroughs Wellcome Fund and the Howard Hughes Medical Institute Medical Research Fellowship program for providing funding for Dr. Witschen.The original “Acknowledgments” isAcknowledgments: The authors would like to thank Douglas Yee (funded by Masonic Cancer Center (MCC) Support Grant, P30-CA077598), and other members of the University of Minnesota Breast Cancer Translational Working Group (BrCa-TWG), for assistance with the cell line and patient Nanostring gene expression experiments. The authors would also like to thank the Elsa Pardee foundation .And should be replaced with:Acknowledgments: The authors would like to thank Douglas Yee (funded by the Masonic Cancer Center (MCC) Support Grant, P30-CA077598), and other members of the University of Minnesota Breast Cancer Translational Working Group (BrCa-TWG), for assistance with the cell line and patient Nanostring gene expression experiments. The authors would also like to thank the Elsa Pardee foundation . The authors would like to acknowledge Ali Khammanivong for providing gRNA sequences and guidance during the generation of the CD44 knockout cell lines. The authors would also like to acknowledge the Burroughs Wellcome Fund and the Howard Hughes Medical Institute Medical Research Fellowship program for providing funding for Patrice M. Witschen.The authors would like to apologize for these omissions from the original manuscript. These changes do not affect the scientific results. The manuscript will be updated, and the original will remain online on the article webpage.


Gordon has been a mentor for me, and one of my best friends for 40 years. What has always impressed me of Gordon was his innate ability to bring people to work together, to build new structures and to facilitate cancer research in creative new ways. Those who knew him will remember his sharp thinking, his wit and great sense of humor and his upbeat spirit and love for life, work and fun. I will never forget his kindness, his balanced advice, his jokes, and his incredibly fast speaking.Professor Gordon McVie qualified in the nineteen sixties in science and medicine at Edinburgh University, he was appointed Foundation Senior Lecturer at the Cancer Research Campaign oncology unit at the University of Glasgow in 1975. He trained in the US, and spent sabbaticals in Paris, Sydney, and Amsterdam.Throughout the eighties, he was Clinical Research Director at the Netherlands Cancer Institute in Amsterdam, and set up their drug discovery programme and the leading intraperitoneal chemotherapy studies in Europe. In the early eighties he was the Chair of the European Organization for Research and Treatment of Cancer (EORTC) Lung Cancer Cooperative Group for 6 years. I met him for the first time in Brussels at one of the first meetings of this newly formed group. He was also appointed Chair of the UICC Fellowships Programme in 1990 for 8 years. From 1994 to 1997 he served as President of the EORTC, and during that time he set up the present Drug Development Group in Brussels, and with the US National Cancer Institute support, the European New Drug Development Network.After almost a decade in the Netherlands, Professor McVie returned to the UK to be the Chief Executive of the Cancer Research Campaign (CRC), which, under his aegis, took over 70 molecules from the lab into clinical trial. He led CRC into a merger with Imperial Cancer Research Fund in 2002, which formed the largest cancer charity in the UK, Cancer Research UK. In the UK he was one of the architects of the Cancer Trials Networks in Scotland, Wales, and England, and was a founding member of the National Cancer Research Institute. His commitment to drug discovery and delivery is evidenced by ~240 patents granted to CRC scientists under his leadership, several drugs registered including carboplatin, temozolomide, olaparib, and abiraterone and the foundation of 10 biotechnology companies based on CRC intellectual property. His clinical interests, apart from new drug discovery and chemoprevention were in the management of cancers of the lung, ovary, liver, breast, and brain.ecancer.org and ecancerpatient.org both online Open Access free websites, with almost 21 million visits in a decade from 191 countries. For 10 years he was Senior Consultant building clinical research at the European Institute of Oncology in Milan.Lately he was visiting professor at Cancer Studies, Kings College London for five years, and was Clinical Research Advisor to the Institute of Molecular Oncology (IFOM) in Milan. He was founding editor of He was a Director and Co-Founder of Ellipses Pharma - an advanced cancer medicines company.Professor McVie was the recipient of numerous awards and has honorary doctorates in science and medicine from six universities. He has served on key committees of AACR and ASCO, and on the boards of the National Cancer Institutes of France, Italy, and Holland. He has authored 360 peer-reviewed articles, and contributed to over 35 books.He was elected as Fellow of the European Association for Cancer Science in 2014, and has been chairman of the European Alliance for Personalized Medicine since early 2016.This is only a short selection of the most important activities Prof. McVie has been engaged in. He was truly a dynamic international presence that recognized the necessity of going beyond the geographical boundaries, bringing people together to create novel structures in the pursuit of the fight against cancer.The author confirms being the sole contributor of this work and has approved it for publication.The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.


This presentation will describe collaborative efforts on the campus of a mid-sized, private university to carry out activities consistent with the Age-Friendly University philosophy. In one program, staff from Career Services and a faculty member from the Department of Health Science coordinated with the President’s College (a continuing education program for adult learners), the Emeriti Association (a group of retired faculty members), and alumni to offer mock interviews for students preparing for graduate school. In another program, steps were taken to coordinate with the office of Diversity, Equity and Inclusion to address Ageism in the Workplace. The presentation will conclude with advice for identifying allies across campus and fostering support for the AFU principles.


In the Sample and procedure subsection of the Methods, there is an error in the first sentence of the first paragraph. The correct sentence is: The ESA is regularly conducted by the Institute for Therapy Research (IFT Institut für Therapieforschung).Information is missing from the Acknowledgments. The correct Acknowledgments are as follows: We thank the IFT Institut für Therapieforschung for providing the data for this analysis.There are errors in the Funding statement. The correct Funding statement is as follows: The 2015 Epidemiological Survey of Substance Abuse (ESA) was supported by funding from the German Federal Ministry of Health (project no. IIA5 –2514DSM200).


Scientific Reports 10.1038/s41598-019-54310-y, published online 09 January 2020Correction to: The Acknowledgements section in this Article is incomplete.“The authors would like to thank CReATE and the ALS Association (US) for the award of the grant supporting the study: “Going Dry: empowering neurofilament-based biomarkers studies for disease monitoring in amyotrophic lateral sclerosis”. We would also like to thank all ALS patients and their families for their support to this research project and we acknowledge the MND Association (UK) for their help in establishing the ALS biomarkers biobank and contributing with significant resources in the sample collection phase and to general aspect of research in ALS. We also acknowledge the support of the North-Thames Local Research Network (London) in the recruitment process and in the collection and processing of biological samples.”should read:“The authors would like to thank CReATe and the ALS Association (US) for the award of the grant supporting the study: “Going Dry: empowering neurofilament-based biomarkers studies for disease monitoring in amyotrophic lateral sclerosis”. The CReATe consortium (U54NS092091) is part of the Rare Diseases Clinical Research Network (RDCRN), an initiative of the Office of Rare Diseases Research (ORDR), NCATS. CReATe is funded through a collaboration between NCATS, and the NINDS. We would also like to thank all ALS patients and their families for their support to this research project and we acknowledge the MND Association (UK) for their help in establishing the ALS biomarkers biobank and contributing with significant resources in the sample collection phase and to general aspect of research in ALS. We also acknowledge the support of the North-Thames Local Research Network (London) in the recruitment process and in the collection and processing of biological samples.”


The affiliation for the third author is incorrect. The correct affiliation is not indicated. Christian Raschner is not affiliated with #2 but with: Department of Sport Science, University of Innsbruck, Innsbruck, Austria.


The authors wish to make the following correction to this paper :In the original version of our article , 8897), insufficient source of funding was given. The authors wish to change the information in the Funding section from:Funding: This research was funded by German Academic Exchange Services, grant number 91727334.to the correct version as follows:Funding: This research was funded by the German Academic Exchange Services (DAAD), grant number 91727334, and by the Deutsche Forschungsgemeinschaft —Projektnummer 427397520.The authors would like to apologize for any inconvenience caused to the readers by these changes.


The Donald P. Kent Award lecture will feature an address by the 2019 Kent Award recipient, Terry Fulmer, PhD, of The John A. Hartford Foundation. The Kent Award is given annually to a member of The Gerontological Society of America who best exemplifies the highest standards of professional leadership in gerontology through teaching, service, and interpretation of gerontology to the larger society. The Robert W. Kleemeier Award lecture will feature an address by the 2019 Kleemeier Award recipient, Steven Zarit of Pennsylvania State University. The Kleemeier Award is given annually to a member of The Gerontological Society of America in recognition for outstanding research in the field of gerontology


In the original article, we neglected to include the funder National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, P50HD089922, to Giorgia Picci and Emma Rose.The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.


The following information is missing from the Funding statement: This study was funded by a grant to Dr. Ahuja from Astex Inc. (GRANT # 120039).There is information missing from the Competing Interests statement. The correct Competing Interests statement is as follows: Dr. Ahuja receives research grant funding from Astex Inc. and the Van Andel Research Institute. She is a consultant for and has licensed methylation biomarkers to Cepheid (PATENT # 10167513). Dr. Ahuja has also served as consultant to Johnson and Johnson, an advisor to Celgene, and a member of the Scientific Advisory Council to the No Stomach for Cancer Foundation. This does not alter our adherence to PLOS ONE policies on sharing data and materials.The raw data underlying the findings of this study are missing from the list of Supporting Information. The authors have provided the data as Supporting Information file S1 Data(XLSX)Click here for additional data file.


The 2019 marks twenty years since Professor Ao Li (黎鳌) passed away. Although he has left us, the “Li Ao Spirit” has lived on and continuously encourages us to climb higher in scientific research and make more contributions to our people and country , was born in Changsha, Hunan Province in May 1917. He graduated from the National Shanghai Medical College in 1941, and had a long and distinguished career in medicine. His various positions over the years included Associate Professor at the National Chung Cheng Medical College, Professor at the Third Military Medical University, Director of the Burn Research Institute of the Third Military Medical University, and the Vice President of the Third Military Medical University. As one of the pioneers and founders of burn medicine in China, professor Li led comprehensive multidisciplinary research on the pathogenesis and prevention of inhalation injury. For his great contribution to the field of burn research, he was not only the recipient of the Everett Idris Evans Memorial Lecture Award of the American Burn Association in 1994, but also won first prize in both the Chinese Science and Technology Advancement Award and the Military Scientific and Technological Progress Award among other accolades.After graduating from high school, Mr. Li was recommended to study in the Department of Physics or Mathematics at Nanjing Central University. However, touched by the sufferings of the general public caused by a lack of medical knowledge and medicine and his father’s illness, Mr. Li was determined to become a doctor. In 1935, he was given the opportunity to study at Shanghai Medical College, where he started his medical career. After graduating, he successively presided over general surgical work in the National Chung Cheng Medical College, the Third Military Medical University and other institutions, saving thousands of lives.In the late 1950s, the number of burn patients increased drastically due to the country’s efforts in increasing steel production, but there were no effective therapies available at that time , which was published by People’s Military Medical Press in 1993  launched the research project named “Study on the Pathogenesis of Early Burn Injury and Wound Healing Mechanism”. The project was sponsored by the National Natural Science Foundation. After five years of hard work, they discovered that macrophages act as an initiator in the uncontrolled inflammatory response after burns, verified that vascular endothelium played the central role in the pathogenesis of early organ damage, clarified the mechanism of the early intestinal damage and intestinal infections, and proposed corresponding treatment measures (Huang et al., Professor Li attached great importance to the growth and cultivation of young scientists. He emphasized training in practice, encouraged young scientists to participate in clinical operation, classroom teaching and laboratory tasks Fig. . He provIn 1986, Professor Li won the National Science and Technology Progress Award. He donated the bonus of the award to establish the Outstanding Paper Award in Burn Medicine for Young Army Scientists to encourage young scientists and technicians to engage in burn research. In 1996, Professor Li won the China Engineering Science and Technology Award and Military Technical Major Contribution Award. Again, he donated the bonus of both awards, a total of 150,000 Chinese Yuan, to set up the Li Ao Burn Medicine Fund so as to reward young and middle-aged scientists who contributed to the development of burn medicine. Ten of the recipients of the Li Ao Burn Medicine Fund have become the leading scientists of burn medicine in China. In 1996, Professor Li was awarded the title of “Outstanding Mentor” by the General Logistics Department of Chinese People’s Liberation Army.Professor Li has devoted his whole life to the cause of burn medicine in China and made a lot of remarkable achievements. Although he left us twenty years ago, we are still always encouraged and inspired by the “Li Ao Spirit” of selflessness, diligence and entrepreneurship. With the great efforts of generations of doctors and scientists, we believe burn medicine research in China will bring about more and more breakthroughs and play a leading role in the international arena.


UNICEF is acknowledged for their support towards the Center for Nutrition Studies, Yenepoya (Deemed to be University). No additional external funding was received for this study.There are errors in the Funding statement. The correct Funding statement is as follows: MB received a grant from The United Nations Children's Fund (UNICEF) for a capacity building workshop on Nutrition Assessment Techniques. The URL of the website is:


There is an error in the Funding statement. The correct number for the National Natural Science Foundation of China is No. 81771231 to HJ and No. 81600995 to YS.the National Natural Science Foundation of China, No. 81974176 to HJ; No. 81901169 to ZC. The corrected funding statement appears below.Additionally, we neglected to include the funder We declared that there were no financial interests in this study. This study was supported by the National Key Research and Development Program of China , the National Natural Science Foundation of China , the National Natural Science Foundation of Hunan Province (No. 2019JJ40363 to RQ), Key Research and Development Program of Hunan Province (No. 2018SK2092 to HJ), Scientific Research Foundation of Health Commission of Hunan Province (No. B2019183 to HJ), The Clinical and rehabilitation fund of Peking University Weiming Biotech Group (No. xywm2015I10 to HJ).The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.


Bioengineering and Translational Medicine, we are pleased to introduce our Editorial Board Member, Professor W. Mark Saltzman. Professor Saltzman is the Goizueta Foundation Professor of Biomedical Engineering, Chemical and Environmental Engineering, and Physiology at Yale University. Professor Saltzman received his BS in chemical engineering from Iowa State University before earning a SM in chemical engineering and a PhD in medical engineering from the Massachusetts Institute of Technology (MIT).In this issue of Professor Saltzman's research has been formative in the fields of controlled drug delivery and tissue engineering. As a trainee in the laboratory of Professor Robert Langer at MIT, Professor Saltzman participated in some of the very earliest work in utilizing polymer scaffolds for cell transplantation with Dr Joseph Vacanti.Professor Saltzman is recognized as a pioneer in quantifying and modeling the transport of macromolecules through synthetic polymers and biological matrices,In addition to his research excellence, Professor Saltzman is passionate about education and has left an indelible mark in this area as well. He has contributed to the emergence of the academic field of biomedical engineering by authoring three original textbooksOver the past 30+ years, Professor Saltzman's contributions as a researcher, educator, and mentor have been immense. He has supervised the research work of over 43 PhD students and 27 postdoctoral researchers who now populate the academic and industry landscape and contribute to his legacy of fundamental discovery and translation in bioengineering. His overall excellence has been recognized via election as Fellow of the American Institute for Medical and Biological Engineering (1997), Fellow of the Biomedical Engineering Society (2010), member of the U.S. National Academy of Medicine (2014), and member of the U.S. National Academy of Engineering (2018). Moreover, Professor Saltzman has set a standard for supportive mentorship that has created a family‐like network among his trainees. He is always available for advice and support, even for those who have long ago left his group, no matter how many other demands on his time there may be. On behalf of his current and former trainees, I express my appreciation and gratitude to Mark for sharing his scientific journey with us and helping to shape our own through his insight and guidance.


In the original article, we neglected to include the funder European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme, grant agreement No. 723951 to RO. The corrected Funding section reads as follows:This work was supported by the EPSRC Cambridge NanoDTC, EP/L015978/1 and the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme, Grant Agreement No. 723951 to RO.The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.


The secondary analysis presented here was not externally funded. The funder of the original study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We acknowledge financial support for the publication costs from the Open Access Publication Fund of the University Medical Center Hamburg-Eppendorf (UKE) and the German Research Foundation (DFG).There are errors in the Funding section. The correct Funding statement is: The original study, of which data were used for analysis, was funded by the German Federal Ministry of Education and Research (


In the published article, there was an error in the Funding statement. The funding from the National Medical Research Council (NMRC) was mistakenly omitted. The correct Funding statement appears below.


The Belt and Road Initiative (BRI) is a development plan proposed by China that aims to build a new platform for international cooperation and create new drivers of shared development. South Asia is a key area in the Belt and Road Initiative, including eight countries. As the BRI implemented, China’s trade with South Asia has been gradually strengthened. This paper explores the influencing factors of China-South Asia trade under the background of the BRI by using Gravity Model of Trade. The results show that economic growth in China and South Asia, increase of savings rate and improvement of industrialization in South Asia has a significant positive effect on China-South Asia trade. While the development gap between China and South Asia has negative effect on China-South Asia trade. The Belt and Road Initiative (BRI) was first proposed by Chinese President Xi Jinping in 2013 . . lnGDPitlnGDPit is negative and significant at 10% level, which is different from the expected sign. This is due to the restriction of economic development level, China mainly imports labor-intensive products from South Asian countries, because countries with lower economic development level have relatively few laborers, and the eight South Asian countries are not China’s main trading partners. The coefficients of lnGDPct, lnGDPPict, lnFDIict and AR(1) is significant at 1% level with the same expected sign. The economic growth in China, China’s invest, the common development of China-South Asia, the path-dependence such as import products from South Asia will encourage South Asia’s export to China. The coefficient of SRit is positive and significant at 5%level. Therefore, the increase of savings rate of South Asia can expand domestic investment of South Asia countries and bring more opportunities to export goods for South Asia.On China’s imports from South Asia as shown in column (3), most facts have significant effect and the same expected sign. The coefficient of BRIit is positive and significant at 10% level in column (3), while not significant in column (1) and (2), This shows that the impact of the Belt and Road Initiative or establish a free trade zone at present is relied on China much more than on South Asia, which was consistent with the findings of Kong (2018) and Zhang (2019) [The coefficient g (2019) , 26. TheTo sum up, we concluded that, GDP, FDI and AR (1) have significant influence on China-South Asia trade, which means that economic growth, development gap, national savings rate and industrialization level are the main influencing factors of trade between China and South Asia. Among them, economic growth, savings rate and industrialization level of both sides have a significant positive impact, while the development gap between China and South Asia has a negative impact on trade between China and South Asia. The impact of BRI on China-South Asia trade is mainly reflected in China’s imports, which shows that the construction of the Belt and Road Initiative still needs to be deepened step by step.The trade volume between China and South Asia has been increasing gradually. But the trade imbalance is obvious—South Asia seriously depend on China’s imports. China mainly exports capital-intensive products to South Asia, while China imports labor-intensive products from South Asia. The economic growth, the development gap, national savings rate and the industrialization level have influence on the trade between China and South Asia. Among these influencing factors, economic growth of China and South Asia counties, savings rate and industrialization level of host countries have significant positive effect on the bilateral trade, while development gap has negative effect. However, the effect of BRI on China-South Asia trade is not significant. The following policy implications are proposed.Promote China’s Going Out Strategy and encourage foreign direct investment. On the one hand, as China improve the value chain and increase the environmental awareness, many capital-intensive and labor-intensive industries, such as construction, manufacturing and energy, are shifting production abroad. Many Chinese multinationals bring advanced technology to invest in countries with rich resources and lower labor costs. On the other hand, expanding China’s investment in South Asia will facilitate technology transfer to domestic firms through spillover, which also promote domestic firms to make the strategic decision to adopt the advanced technology and stimulate innovation and creativity.China and South Asia should deepen the cooperation of production. China has a relatively high level of industrialization. Deepening production capacity cooperation through building production bases and economic and trade cooperation zones can promote the industrialization of South Asia. The improvement of the industrialization expands the range of commodities of China-South Asia trade and optimize the trade structure.Through combing the existing literature, although there are innovations, there are still limitations. For example, in terms of choosing influencing factors, although the research pursues the comprehensiveness of the theme, there may be other factors that have a certain impact on bilateral trade. In addition, the implementation of the Belt and Road Initiative policy is affected by many parties, and the implementation of specific projects and their impact on trade and economy need longer time and data to further prove and analyze. This study suggests that future research should continue to track and explore the trade influencing factors of South Asia and other countries and regions along the Belt and Road Initiative.S1 Data(XLSX)Click here for additional data file.


In January, 2023, the Science and Security Board of the Bulletin of the Atomic Scientists moved the hands of the Doomsday Clock forward to 90 s before midnight, reflecting the growing risk of nuclear war.Current nuclear arms control and non‐proliferation efforts are inadequate to protect the world's population against the threat of nuclear war by design, error, or miscalculation. The Treaty on the Non‐Proliferation of Nuclear Weapons (NPT) commits each of the 190 participating nations”to pursue negotiations in good faith on effective measures relating to cessation of the nuclear arms race at an early date and to nuclear disarmament, and on a treaty on general and complete disarmament under strict and effective international control”.Any use of nuclear weapons would be catastrophic for humanity. Even a “limited” nuclear war involving only 250 of the 13,000 nuclear weapons in the world could kill 120 million people outright and cause global climate disruption leading to a nuclear famine, putting 2 billion people at risk.http://www.ippnw.org).The health community has had a crucial role in efforts to reduce the risk of nuclear war and must continue to do so in the future.In 2007, the IPPNW launched the International Campaign to Abolish Nuclear Weapons, which grew into a global civil society campaign with hundreds of partner organisations. A pathway to nuclear abolition was created with the adoption of the Treaty on the Prohibition of Nuclear Weapons in 2017, for which the International Campaign to Abolish Nuclear Weapons was awarded the 2017 Nobel Peace Prize. International medical organisations, including the International Committee of the Red Cross, the IPPNW, the World Medical Association, the World Federation of Public Health Associations, and the International Council of Nurses, had key roles in the process leading up to the negotiations, and in the negotiations themselves, presenting the scientific evidence about the catastrophic health and environmental consequences of nuclear weapons and nuclear war. They continued this important collaboration during the First Meeting of the States Parties to the Treaty on the Prohibition of Nuclear Weapons, which currently has 92 signatories, including 68 member states.We now call on health professional associations to inform their members worldwide about the threat to human survival and to join with the IPPNW to support efforts to reduce the near‐term risks of nuclear war, including three immediate steps on the part of nuclear‐armed states and their allies: first, adopt a no first use policy;The danger is great and growing. The nuclear armed states must eliminate their nuclear arsenals before they eliminate us. The health community played a decisive part during the Cold War and more recently in the development of the Treaty on the Prohibition of Nuclear Weapons. We must take up this challenge again as an urgent priority, working with renewed energy to reduce the risks of nuclear war and to eliminate nuclear weapons.Respective authors were paid by their employers. Chris Zielinski's time was funded by International Physicians for the Prevention of Nuclear War.KB‐D is a full‐time employee of the American Medical Association, working as the Editor‐in‐Chief of JAMA and the JAMA Network. AH is principal investigator of the Pathfinder Initiative 2020–2025, co‐investigator of Sustainable Healthy Food Systems research programme 2017–2023, and co‐investigator of Complex Urban Systems for Sustainability and Health 2017–2023, all funded by the Wellcome Trust, with additional funding from the Oak Foundation for the Pathfinder Initiative, and he reports royalties from Cambridge University Press for the coauthored book Planetary Health; consultancy fees paid to his institution from the Wellcome Trust for his role as Senior Advisor on Climate Change and Health in 2021; travel/meeting support from WHO and Human Frontiers Science Program; and he is a member of the Cool Roofs trial steering committee Nouna Research Centre, Burkina Faso/University of Heidelberg, is Co‐chair of the International Advisory Committee, NIHR Clean‐Air (Africa) Global Health Research Unit, is a member of the Independent Advisory Group, Collaboration for the Establishment of an African Population Cohort Consortium, and he was Co‐chair of the InterAcademy Partnership, Climate Change and Health Working Group 2019–2022 and Co‐chair of the Academy of Medical Sciences/Royal Society working group on ‘A healthy future—tackling climate change mitigation and human health together’ 2020–2021 . IH reports honoraria for several speaking engagements, all donated to Back from the Brink, the International Physicians for the Prevention of Nuclear War, or Physicians for Social Responsibility; travel/ meeting support for Nobel Peace Laureates' Summit, the World Federation of Public Health Associations World Congress, and the UN Human Rights Commission Youth Summit; and he is a member of the steering committee of Back from the Brink and the International Steering Group of the International Campaign to Abolish Nuclear Weapons, a Board member of the International Physicians for the Prevention of Nuclear War and Physicians for Social Responsibility, and a Trustee of the Phillips Exeter Academy . MGMOR reports research grants from the Dutch Research Council, NOW (grant number COMPL.21COV.001) and from the Netherlands Organisation for Health Research ZonMw (grant number 09120012010063) and he is Chair of the Dutch guideline committee on cognitive impairments and dementia. TR reports a contract with the Institute for Energy and Environmental Research (USA) for papers addressing the health and environmental consequences of nuclear testing in multiple locations, including Australia, French Polynesia, central Pacific, and China; honorarium from The Choisun Ilbo media group in South Korea for a lecture on nuclear weapons in 2022 and for nuclear weapons presentations from Hyogo Medical Practitioners Association (Japan), Peace Boat (Japan), and the University of Sydney; he was an expert witness on radiation and health for Environmental Justice Australia acting for Mine‐Free Glenaladale regarding proposed Fingerboards Mineral Sands Mine to the Victorian Government Fingerboards Inquiry and Advisory Committee; he is a member of RV3 Rotavirus Vaccine Development Scientific Advisory Board, Murdoch Children's Research Institute/ Royal Children's Hospital; he is a member of the Committee of International Campaign to Abolish Nuclear Weapons Australia; he is a member of the Internet Peace Prize Award Committee ; he was a member of the Victorian International Humanitarian Law Advisory Committee, Australian Red Cross; he is a Board member of the Initiative for Peacebuilding, Faculty of Arts, University of Melbourne; he is an At‐large Board member of the International Physicians for the Prevention of Nuclear War; he was Co‐president of the International Physicians for the Prevention of Nuclear War 2012–23; and he is Honorary Principal Fellow, Melbourne School of Population and Global Health, University of Melbourne. PY reports grants from Atea Pharmaceuticals; honoraria for lectures, presentations, and educational events from bioMérieux and Pfizer Pharmaceuticals; fees for participation on an advisory board from Pfizer Pharmaceuticals; and he is a member of the Antimicrobial Stewardship Study Group Executive Committee (2022–2024) and the Clinical Practice Guideline Panel on Vaccinations in Immunocompromised hosts for the European Society of Clinical Microbiology and Infectious Diseases. CZ reports consulting fees for his role as senior adviser on the international journals project from the International Physicians for the Prevention of Nuclear War. All the other authors declare no competing interests.


Funding statement.In the published article, there was a mistake in the Original text: This research was supported by the National Alliance for Research on Schizophrenia & Depressio (NARSAD) Young Investigator Award and K23 MH067705 to EN and K01 DA020485 to JE. AK was supported by grant Ministry of Education and Science of the RK AP08856595. JA was supported by R01-DA022221-02S2 (PI: DelBello).Due to an oversight by the authors during proofing, the order of grant support was listed incorrectly, and some awkward wording was not corrected. As a condition of supporting the research publication costs, the Ministry of Education and Science in the Republic of Kazakhstan requires that it must be listed first in the funding statement. The correct Funding statement appears below.


In the published article, there was an error in the Funding statement. The grant number was mistakenly omitted. The correct Funding statement appears below.This material is based upon work supported by, or in part by, the Army Research Laboratory and the Army Research Office under contract/grant number W911NF-19-0419.The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.


The corrected Acknowledgements statement appears below.In the published article, Vounba P, Loul S, Tamadea LF, Siawaya JFD. Microbiology laboratories involved in disease and antimicrobial resistance surveillance: Strengths and challenges of the central African states. Afr J Lab Med. 2022;11(1), a1570. The original incorrect wording:We sincerely thank Dr Skander Hathroubi  for his contribution by reading and correcting the first draft of the manuscript.The revised and updated wording:We sincerely thank Dr Skander Hathroubi  for his contribution by reading and correcting the first draft of the manuscript. This study was commissioned and supported by the Regional Disease Surveillance Systems Enhancement (REDISSE) project in Central Africa, which is financially supported by the World Bank and managed by the Economic Community of Central African States (ECCAS). We would like to thank ECCAS and the World Bank for supporting our efforts through REDISSE.The authors apologise for this error. The correction does not change the study’s findings of significance or overall interpretation of the study’s results or the scientific conclusions of the article in any way.


Funding statement appears below:In the original article, there was an error in the Funding statement. . The correct “This study was supported by the project of the National Key R&D Program of China (No. 2019YFC1712105), and the Major Basic Research Project of Shandong Natural Science Foundation (No. ZR2020ZD17).”The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.


In the published article, there was an error in the Funding statement. We missed out an extra funder. The correct Funding statement appears below:The CERTAIN registry received funding from Astellas and Novartis. The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication. All authors declare no other competing interests. The authors gratefully acknowledge the funding of the CERTAIN Registry by a grant from the Dietmar Hopp Stiftung, the European Society for Paediatric Nephrology (ESPN) and The German Society for Paediatric Nephrology (GPN). JKi acknowledges funding from a MRC NIHR fellowship (MR/V037900/1). CS acknowledges funding from the European Commision’s Horizon 2020 Research and Innovation Programme (grant no. 952512). VK acknowledges funding from an NIHR Fellowship (PDF-2016-09-065) and as a Paul I. Terasaki Scholar.VK acknowledges funding from the National Institute for Health Research Blood and Transplant Research Unit  in Organ Donation and Transplantation at the University of Cambridge in collaboration with Newcastle University and in partnership with NHS Blood and Transplant (NHSBT). The views expressed are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research, the Department of Health or National Health Service Blood and Transplant.The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.


There are errors in the Funding section. The correct Funding statement is: This research was supported by the Korean Association of Cardiopulmonary Resuscitation (no. 2021–001) and the Soonchunhyang University Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.


Funding statement. The grant number for funding from the Zhejiang Provincial Natural Science Foundation of China was incorrectly reported as “No. LR22C02003”. The correct Funding statement appears below.In the published article, there was an error in the “This work was funded by the National Natural Science Foundation of China under Grant No. 32000234, and the Zhejiang Provincial Natural Science Foundation of China under Grant No. LR22C020003, the Major Science and Technology Special Project of Variety Breeding of Zhejiang Province (2021C02067-7), and the State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products under Grant No. 2021DG700024-KF202102”.The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.